

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.95511408 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.95511408 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.43330791 |
| 4 | response to peptidoglycan (GO:0032494) | 4.32584060 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.01211970 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.01211970 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 3.96091212 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 3.89039099 |
| 9 | detection of other organism (GO:0098543) | 3.75107687 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 3.74945504 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.70277041 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.69419041 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.69213257 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 3.67275877 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 3.63457416 |
| 16 | detection of bacterium (GO:0016045) | 3.59619688 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56231722 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41886229 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37306091 |
| 20 | lysine metabolic process (GO:0006553) | 3.35749899 |
| 21 | lysine catabolic process (GO:0006554) | 3.35749899 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.30532398 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28635618 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27075254 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.26945978 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 3.26945978 |
| 27 | protein carboxylation (GO:0018214) | 3.25659962 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.25659962 |
| 29 | valine metabolic process (GO:0006573) | 3.23599445 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.22511008 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.20605844 |
| 32 | glycosphingolipid catabolic process (GO:0046479) | 3.19988960 |
| 33 | glyoxylate metabolic process (GO:0046487) | 3.19789543 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.19713976 |
| 35 | L-phenylalanine catabolic process (GO:0006559) | 3.19713976 |
| 36 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.19470333 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.19400688 |
| 38 | barbed-end actin filament capping (GO:0051016) | 3.19396989 |
| 39 | kynurenine metabolic process (GO:0070189) | 3.14658368 |
| 40 | pinocytosis (GO:0006907) | 3.13793540 |
| 41 | complement activation, classical pathway (GO:0006958) | 3.13412465 |
| 42 | protein localization to endosome (GO:0036010) | 3.12176413 |
| 43 | regulation of leukocyte degranulation (GO:0043300) | 3.11935706 |
| 44 | apoptotic cell clearance (GO:0043277) | 3.10996132 |
| 45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10944538 |
| 46 | cellular extravasation (GO:0045123) | 3.05740518 |
| 47 | complement activation, alternative pathway (GO:0006957) | 3.02744462 |
| 48 | aromatic amino acid family catabolic process (GO:0009074) | 3.01886617 |
| 49 | regulation of B cell differentiation (GO:0045577) | 3.00043294 |
| 50 | complement activation (GO:0006956) | 2.98516304 |
| 51 | B cell receptor signaling pathway (GO:0050853) | 2.97308443 |
| 52 | regulation of fibrinolysis (GO:0051917) | 2.97070491 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.96863427 |
| 54 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.95321048 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95122258 |
| 56 | 2-oxoglutarate metabolic process (GO:0006103) | 2.93967248 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 2.93219130 |
| 58 | sulfur amino acid catabolic process (GO:0000098) | 2.92911129 |
| 59 | detection of biotic stimulus (GO:0009595) | 2.90832844 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90223793 |
| 61 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89394890 |
| 62 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88501799 |
| 63 | pentose-phosphate shunt (GO:0006098) | 2.87657064 |
| 64 | indole-containing compound catabolic process (GO:0042436) | 2.87597174 |
| 65 | indolalkylamine catabolic process (GO:0046218) | 2.87597174 |
| 66 | tryptophan catabolic process (GO:0006569) | 2.87597174 |
| 67 | cellular response to type I interferon (GO:0071357) | 2.87344857 |
| 68 | type I interferon signaling pathway (GO:0060337) | 2.87344857 |
| 69 | glycolipid catabolic process (GO:0019377) | 2.87194998 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 2.86064116 |
| 71 | regulation of protein activation cascade (GO:2000257) | 2.86036063 |
| 72 | urea metabolic process (GO:0019627) | 2.85715500 |
| 73 | urea cycle (GO:0000050) | 2.85715500 |
| 74 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84893786 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84310464 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83783528 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82289620 |
| 78 | regulation of cholesterol storage (GO:0010885) | 2.80376141 |
| 79 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.79993960 |
| 80 | regulation of triglyceride catabolic process (GO:0010896) | 2.78540260 |
| 81 | oligosaccharide catabolic process (GO:0009313) | 2.77281214 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 2.77264045 |
| 83 | myeloid dendritic cell differentiation (GO:0043011) | 2.76768191 |
| 84 | tricarboxylic acid metabolic process (GO:0072350) | 2.75935963 |
| 85 | regulation of complement activation (GO:0030449) | 2.75604585 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 2.75377791 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75098352 |
| 88 | germinal center formation (GO:0002467) | 2.74191918 |
| 89 | high-density lipoprotein particle remodeling (GO:0034375) | 2.73717248 |
| 90 | granulocyte activation (GO:0036230) | 2.73560400 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 2.73368189 |
| 92 | low-density lipoprotein particle clearance (GO:0034383) | 2.72793402 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.72740705 |
| 94 | bile acid biosynthetic process (GO:0006699) | 2.72157374 |
| 95 | negative regulation of phagocytosis (GO:0050765) | 2.70627093 |
| 96 | tryptophan metabolic process (GO:0006568) | 2.70542651 |
| 97 | positive regulation of interferon-alpha production (GO:0032727) | 2.69926050 |
| 98 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.68942498 |
| 99 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.67807732 |
| 100 | cysteine metabolic process (GO:0006534) | 2.67635445 |
| 101 | ethanol oxidation (GO:0006069) | 2.66744084 |
| 102 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64769456 |
| 103 | positive regulation of leukocyte degranulation (GO:0043302) | 2.63404238 |
| 104 | response to laminar fluid shear stress (GO:0034616) | 2.63110489 |
| 105 | T-helper 1 type immune response (GO:0042088) | 2.62700826 |
| 106 | response to host immune response (GO:0052572) | 2.62480375 |
| 107 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62480375 |
| 108 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.61741614 |
| 109 | leukocyte aggregation (GO:0070486) | 2.61606976 |
| 110 | NADPH regeneration (GO:0006740) | 2.60801629 |
| 111 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.60220831 |
| 112 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.60220831 |
| 113 | modulation by symbiont of host immune response (GO:0052553) | 2.60220831 |
| 114 | positive regulation by symbiont of host defense response (GO:0052509) | 2.60220831 |
| 115 | modulation by symbiont of host defense response (GO:0052031) | 2.60220831 |
| 116 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.60220831 |
| 117 | protein activation cascade (GO:0072376) | 2.59657138 |
| 118 | nitrogen cycle metabolic process (GO:0071941) | 2.59455291 |
| 119 | myeloid cell activation involved in immune response (GO:0002275) | 2.59308301 |
| 120 | macrophage activation (GO:0042116) | 2.57766151 |
| 121 | respiratory burst (GO:0045730) | 2.57121890 |
| 122 | phospholipid efflux (GO:0033700) | 2.55917493 |
| 123 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55679426 |
| 124 | response to host (GO:0075136) | 2.55679426 |
| 125 | response to host defenses (GO:0052200) | 2.55679426 |
| 126 | regulation of tolerance induction (GO:0002643) | 2.55505814 |
| 127 | mannose metabolic process (GO:0006013) | 2.55419706 |
| 128 | positive regulation of mast cell activation (GO:0033005) | 2.55172395 |
| 129 | negative regulation of sterol transport (GO:0032372) | 2.54609114 |
| 130 | negative regulation of cholesterol transport (GO:0032375) | 2.54609114 |
| 131 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54601970 |
| 132 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.54081449 |
| 133 | neutrophil activation (GO:0042119) | 2.53318403 |
| 134 | virion attachment to host cell (GO:0019062) | 2.53274202 |
| 135 | adhesion of symbiont to host cell (GO:0044650) | 2.53274202 |
| 136 | regulation of interferon-alpha production (GO:0032647) | 2.52740488 |
| 137 | myeloid dendritic cell activation (GO:0001773) | 2.52203470 |
| 138 | amino-acid betaine metabolic process (GO:0006577) | 2.51389390 |
| 139 | angiogenesis involved in wound healing (GO:0060055) | 2.51363134 |
| 140 | reverse cholesterol transport (GO:0043691) | 2.51145782 |
| 141 | regulation of mononuclear cell migration (GO:0071675) | 2.50501854 |
| 142 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.50423257 |
| 143 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49796073 |
| 144 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.48576557 |
| 145 | macrophage activation involved in immune response (GO:0002281) | 2.48113170 |
| 146 | response to thyroid hormone (GO:0097066) | 2.47910227 |
| 147 | positive regulation of histone deacetylation (GO:0031065) | 2.47885891 |
| 148 | fatty acid beta-oxidation (GO:0006635) | 2.47621779 |
| 149 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.47457784 |
| 150 | positive regulation of type 2 immune response (GO:0002830) | 2.47324334 |
| 151 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.47195921 |
| 152 | oxaloacetate metabolic process (GO:0006107) | 2.46319764 |
| 153 | regulation of type 2 immune response (GO:0002828) | 2.46184123 |
| 154 | negative regulation of innate immune response (GO:0045824) | 2.46048181 |
| 155 | plasma lipoprotein particle remodeling (GO:0034369) | 2.46027912 |
| 156 | protein-lipid complex remodeling (GO:0034368) | 2.46027912 |
| 157 | macromolecular complex remodeling (GO:0034367) | 2.46027912 |
| 158 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.45760502 |
| 159 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.45760502 |
| 160 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.45013863 |
| 161 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.44976139 |
| 162 | phospholipid homeostasis (GO:0055091) | 2.44869752 |
| 163 | positive regulation of blood coagulation (GO:0030194) | 2.44414496 |
| 164 | positive regulation of hemostasis (GO:1900048) | 2.44414496 |
| 165 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44096890 |
| 166 | cellular modified amino acid catabolic process (GO:0042219) | 2.44093543 |
| 167 | defense response to protozoan (GO:0042832) | 2.43970653 |
| 168 | response to type I interferon (GO:0034340) | 2.43848224 |
| 169 | B cell mediated immunity (GO:0019724) | 2.43731093 |
| 170 | N-acetylneuraminate metabolic process (GO:0006054) | 2.42982812 |
| 171 | regulation of plasminogen activation (GO:0010755) | 2.42734656 |
| 172 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.42727792 |
| 173 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.42359878 |
| 174 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.42288076 |
| 175 | ceramide catabolic process (GO:0046514) | 2.42103118 |
| 176 | homocysteine metabolic process (GO:0050667) | 2.41717418 |
| 177 | positive regulation of coagulation (GO:0050820) | 2.41652659 |
| 178 | positive regulation of mast cell degranulation (GO:0043306) | 2.41610707 |
| 179 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.41610707 |
| 180 | positive thymic T cell selection (GO:0045059) | 2.41365926 |
| 181 | regulation of monocyte chemotaxis (GO:0090025) | 2.41341131 |
| 182 | regulation of superoxide anion generation (GO:0032928) | 2.40693245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.98048784 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.01152238 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.62736421 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.45078088 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.30164541 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.65828376 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64489032 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55861731 |
| 9 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50268545 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.47066692 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.46842815 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.44410808 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.25610820 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.25363966 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23953632 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22205117 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20789831 |
| 18 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.17777014 |
| 19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15490722 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13803756 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13759376 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13492786 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10491853 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09256090 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.03632645 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.98774735 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.98511154 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95287837 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92222288 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90174377 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.88115846 |
| 32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84930090 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.83860037 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83066606 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82972961 |
| 36 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.79491455 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.79029095 |
| 38 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78353952 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.77337102 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76635008 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.75956941 |
| 42 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75422731 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72127847 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70685209 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61676473 |
| 46 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61498935 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.55635201 |
| 48 | * MYB_26560356_Chip-Seq_TH2_Human | 1.53906407 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53243576 |
| 50 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52994361 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52771608 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49620149 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.47052265 |
| 54 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.45413864 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43528056 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41394999 |
| 57 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41269740 |
| 58 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40714365 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40697438 |
| 60 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.40632582 |
| 61 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39963823 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39922063 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37520506 |
| 64 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33417277 |
| 65 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32685077 |
| 66 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32636943 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30863716 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30237388 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30107841 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28397365 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25108626 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24975614 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23241829 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21433376 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19534991 |
| 76 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.19364825 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.18885601 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16556597 |
| 79 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15540259 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15224623 |
| 81 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14704624 |
| 82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14634519 |
| 83 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14214130 |
| 84 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13517253 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13331718 |
| 86 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12263349 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11926196 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11144379 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09924044 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09642380 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09176023 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08051788 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07608455 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07497413 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06775971 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06648922 |
| 97 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03515257 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02313349 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01391114 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01081615 |
| 101 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00963979 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00430009 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00243250 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00021728 |
| 105 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99939429 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.99197925 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98970998 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98590996 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97977740 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97276081 |
| 111 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96544393 |
| 112 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96357258 |
| 113 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95653878 |
| 114 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.95521760 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95015353 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93954977 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91230169 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89282073 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.88722858 |
| 120 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87687177 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85292396 |
| 122 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84280200 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83601090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.51790935 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.24172178 |
| 3 | MP0009840_abnormal_foam_cell | 2.85149970 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.79134863 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.64451081 |
| 6 | MP0005365_abnormal_bile_salt | 2.59153955 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.52843007 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.33386209 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.26314096 |
| 10 | MP0003303_peritoneal_inflammation | 2.25870674 |
| 11 | MP0000685_abnormal_immune_system | 2.20847006 |
| 12 | MP0005451_abnormal_body_composition | 2.20787700 |
| 13 | MP0003436_decreased_susceptibility_to | 2.19141361 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.19086886 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.13568347 |
| 16 | MP0003252_abnormal_bile_duct | 1.96790558 |
| 17 | MP0009785_altered_susceptibility_to | 1.89778321 |
| 18 | MP0001800_abnormal_humoral_immune | 1.87776125 |
| 19 | MP0001790_abnormal_immune_system | 1.87402464 |
| 20 | MP0005387_immune_system_phenotype | 1.87402464 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.86595941 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.84249003 |
| 23 | MP0006054_spinal_hemorrhage | 1.77985765 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.77569812 |
| 25 | MP0008260_abnormal_autophagy | 1.72158654 |
| 26 | MP0005025_abnormal_response_to | 1.71675420 |
| 27 | MP0002419_abnormal_innate_immunity | 1.70576914 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.69432593 |
| 29 | MP0003828_pulmonary_edema | 1.66421043 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.65898828 |
| 31 | MP0003724_increased_susceptibility_to | 1.64683890 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.63460395 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.58831045 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.56748123 |
| 35 | MP0005083_abnormal_biliary_tract | 1.56187842 |
| 36 | MP0002723_abnormal_immune_serum | 1.52718944 |
| 37 | MP0000609_abnormal_liver_physiology | 1.52175645 |
| 38 | MP0003279_aneurysm | 1.46743932 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.45881217 |
| 40 | MP0001819_abnormal_immune_cell | 1.44096720 |
| 41 | MP0006082_CNS_inflammation | 1.44079084 |
| 42 | MP0005671_abnormal_response_to | 1.42839014 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.42269193 |
| 44 | MP0008469_abnormal_protein_level | 1.39359623 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.37452468 |
| 46 | MP0003448_altered_tumor_morphology | 1.36777141 |
| 47 | MP0004947_skin_inflammation | 1.35401346 |
| 48 | MP0001666_abnormal_nutrient_absorption | 1.35392344 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.35050317 |
| 50 | MP0005332_abnormal_amino_acid | 1.32923818 |
| 51 | MP0003453_abnormal_keratinocyte_physiol | 1.32682794 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.32128686 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.31865334 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.31076776 |
| 55 | MP0001958_emphysema | 1.29073653 |
| 56 | MP0002398_abnormal_bone_marrow | 1.28479297 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.27361044 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.25728647 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.25218895 |
| 60 | MP0000716_abnormal_immune_system | 1.24890550 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.24605325 |
| 62 | MP0001853_heart_inflammation | 1.21379143 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.21296783 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.19752131 |
| 65 | MP0002405_respiratory_system_inflammati | 1.19734348 |
| 66 | MP0009278_abnormal_bone_marrow | 1.16723650 |
| 67 | MP0005257_abnormal_intraocular_pressure | 1.16222093 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.16028140 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 1.15937438 |
| 70 | MP0003690_abnormal_glial_cell | 1.15717244 |
| 71 | MP0005164_abnormal_response_to | 1.15302227 |
| 72 | MP0002254_reproductive_system_inflammat | 1.15177952 |
| 73 | MP0005023_abnormal_wound_healing | 1.14910387 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14822537 |
| 75 | MP0002722_abnormal_immune_system | 1.14571899 |
| 76 | MP0002933_joint_inflammation | 1.13765495 |
| 77 | MP0005310_abnormal_salivary_gland | 1.13387722 |
| 78 | MP0001849_ear_inflammation | 1.13209577 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 1.13021116 |
| 80 | MP0001545_abnormal_hematopoietic_system | 1.13021116 |
| 81 | MP0005390_skeleton_phenotype | 1.12337633 |
| 82 | * MP0002429_abnormal_blood_cell | 1.10919961 |
| 83 | MP0004510_myositis | 1.10129040 |
| 84 | MP0000598_abnormal_liver_morphology | 1.10071409 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 1.09838814 |
| 86 | MP0004130_abnormal_muscle_cell | 1.09586762 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 1.08870889 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 1.08085525 |
| 89 | MP0003329_amyloid_beta_deposits | 1.08010907 |
| 90 | MP0000343_altered_response_to | 1.07276204 |
| 91 | MP0001542_abnormal_bone_strength | 1.06691926 |
| 92 | MP0009764_decreased_sensitivity_to | 1.05117220 |
| 93 | MP0004883_abnormal_blood_vessel | 1.04658819 |
| 94 | MP0003183_abnormal_peptide_metabolism | 1.03769022 |
| 95 | MP0001851_eye_inflammation | 1.03679823 |
| 96 | MP0001873_stomach_inflammation | 1.03630619 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 1.03052263 |
| 98 | MP0003075_altered_response_to | 1.02749498 |
| 99 | MP0008004_abnormal_stomach_pH | 1.02264478 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 1.01324188 |
| 101 | MP0003763_abnormal_thymus_physiology | 1.00287855 |
| 102 | MP0009763_increased_sensitivity_to | 0.99904870 |
| 103 | MP0005670_abnormal_white_adipose | 0.95660582 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.94471851 |
| 105 | MP0002006_tumorigenesis | 0.93582312 |
| 106 | MP0004858_abnormal_nervous_system | 0.93489295 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.93038413 |
| 108 | MP0005275_abnormal_skin_tensile | 0.91888308 |
| 109 | MP0000249_abnormal_blood_vessel | 0.91861775 |
| 110 | MP0003795_abnormal_bone_structure | 0.89873538 |
| 111 | MP0000604_amyloidosis | 0.88673027 |
| 112 | MP0005165_increased_susceptibility_to | 0.82929260 |
| 113 | MP0000858_altered_metastatic_potential | 0.81744492 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.79911444 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.79107453 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.78788448 |
| 117 | MP0005166_decreased_susceptibility_to | 0.77972937 |
| 118 | MP0003195_calcinosis | 0.75685741 |
| 119 | MP0003091_abnormal_cell_migration | 0.74930413 |
| 120 | MP0002928_abnormal_bile_duct | 0.74444606 |
| 121 | MP0003186_abnormal_redox_activity | 0.73975710 |
| 122 | MP0004019_abnormal_vitamin_homeostasis | 0.73853014 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.71576979 |
| 124 | MP0003866_abnormal_defecation | 0.71542374 |
| 125 | MP0001663_abnormal_digestive_system | 0.69294531 |
| 126 | MP0000490_abnormal_crypts_of | 0.68796974 |
| 127 | MP0000920_abnormal_myelination | 0.68656322 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.62780909 |
| 129 | MP0008874_decreased_physiological_sensi | 0.62635649 |
| 130 | MP0002060_abnormal_skin_morphology | 0.60509218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.33433321 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.33433321 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.33433321 |
| 4 | Deep venous thrombosis (HP:0002625) | 3.96919776 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.39262963 |
| 6 | Complement deficiency (HP:0004431) | 3.26440580 |
| 7 | Xanthomatosis (HP:0000991) | 3.22258468 |
| 8 | Cellulitis (HP:0100658) | 3.09043373 |
| 9 | Orchitis (HP:0100796) | 3.08177877 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06238605 |
| 11 | Colitis (HP:0002583) | 3.01423047 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 2.92695717 |
| 13 | Chronic otitis media (HP:0000389) | 2.90349828 |
| 14 | Interstitial pulmonary disease (HP:0006530) | 2.89919421 |
| 15 | Protrusio acetabuli (HP:0003179) | 2.88026032 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.87867185 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.78047298 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75260535 |
| 19 | Cerebral aneurysm (HP:0004944) | 2.72660475 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 2.71969106 |
| 21 | Spontaneous hematomas (HP:0007420) | 2.69546182 |
| 22 | Abnormality of the nasal mucosa (HP:0000433) | 2.67251315 |
| 23 | Abnormality of complement system (HP:0005339) | 2.64660046 |
| 24 | Peritonitis (HP:0002586) | 2.64191100 |
| 25 | Recurrent bronchitis (HP:0002837) | 2.61630626 |
| 26 | Joint hemorrhage (HP:0005261) | 2.60961000 |
| 27 | Mitral stenosis (HP:0001718) | 2.59893000 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.59560942 |
| 29 | Gingivitis (HP:0000230) | 2.59520902 |
| 30 | Optic neuritis (HP:0100653) | 2.59520552 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.59520552 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.59094593 |
| 33 | Recurrent abscess formation (HP:0002722) | 2.57195666 |
| 34 | Obstructive lung disease (HP:0006536) | 2.56524018 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56524018 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.54851127 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.54227472 |
| 38 | Recurrent viral infections (HP:0004429) | 2.54105839 |
| 39 | Glomerulonephritis (HP:0000099) | 2.52525507 |
| 40 | Purpura (HP:0000979) | 2.52467230 |
| 41 | Myocardial infarction (HP:0001658) | 2.52174187 |
| 42 | Hematochezia (HP:0002573) | 2.50406508 |
| 43 | Myositis (HP:0100614) | 2.49919143 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.48257859 |
| 45 | Agammaglobulinemia (HP:0004432) | 2.47613741 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.45882276 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.44617631 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42746804 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.42746804 |
| 50 | Papilloma (HP:0012740) | 2.42589600 |
| 51 | Verrucae (HP:0200043) | 2.42589600 |
| 52 | IgM deficiency (HP:0002850) | 2.40965455 |
| 53 | Thrombocytosis (HP:0001894) | 2.40196980 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.39782640 |
| 55 | Hyperlipoproteinemia (HP:0010980) | 2.39597795 |
| 56 | Nasal polyposis (HP:0100582) | 2.36421915 |
| 57 | Intrahepatic cholestasis (HP:0001406) | 2.34917489 |
| 58 | Neurofibrillary tangles (HP:0002185) | 2.32082016 |
| 59 | Ketosis (HP:0001946) | 2.27182171 |
| 60 | Stomatitis (HP:0010280) | 2.26671149 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.26409011 |
| 62 | Increased IgE level (HP:0003212) | 2.24840105 |
| 63 | Disinhibition (HP:0000734) | 2.23320255 |
| 64 | Hyperammonemia (HP:0001987) | 2.23174655 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.20147816 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.20147816 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.20147816 |
| 68 | Abnormal platelet function (HP:0011869) | 2.19753904 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.19753904 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.19616772 |
| 71 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18685610 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.18464698 |
| 73 | Aortic aneurysm (HP:0004942) | 2.17937764 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.17443033 |
| 75 | Spondylolisthesis (HP:0003302) | 2.16367776 |
| 76 | Polycythemia (HP:0001901) | 2.16067322 |
| 77 | Nonimmune hydrops fetalis (HP:0001790) | 2.13828903 |
| 78 | Abnormality of macrophages (HP:0004311) | 2.13606063 |
| 79 | Malnutrition (HP:0004395) | 2.11638119 |
| 80 | Epistaxis (HP:0000421) | 2.11552781 |
| 81 | Gingival bleeding (HP:0000225) | 2.10912191 |
| 82 | Hypobetalipoproteinemia (HP:0003563) | 2.10474543 |
| 83 | Nuclear cataract (HP:0100018) | 2.09900451 |
| 84 | Urticaria (HP:0001025) | 2.09561210 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.09424154 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 2.09000204 |
| 87 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.08884789 |
| 88 | Abnormality of the intrinsic pathway (HP:0010989) | 2.07821698 |
| 89 | Vasculitis (HP:0002633) | 2.07737024 |
| 90 | Prolonged partial thromboplastin time (HP:0003645) | 2.07618409 |
| 91 | Nephritis (HP:0000123) | 2.07363532 |
| 92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06296778 |
| 93 | Emphysema (HP:0002097) | 2.04625969 |
| 94 | Upper motor neuron abnormality (HP:0002127) | 2.01501936 |
| 95 | Petechiae (HP:0000967) | 2.00373993 |
| 96 | Aortic dissection (HP:0002647) | 1.99900444 |
| 97 | Recurrent skin infections (HP:0001581) | 1.99722904 |
| 98 | Meningitis (HP:0001287) | 1.99220020 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98950042 |
| 100 | Hemoptysis (HP:0002105) | 1.97529377 |
| 101 | Hypoalphalipoproteinemia (HP:0003233) | 1.96816266 |
| 102 | Recurrent fungal infections (HP:0002841) | 1.96212098 |
| 103 | Thin bony cortex (HP:0002753) | 1.94100310 |
| 104 | Hypoglycemic coma (HP:0001325) | 1.92898773 |
| 105 | Thoracic kyphosis (HP:0002942) | 1.92387907 |
| 106 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91912381 |
| 107 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91912381 |
| 108 | Loss of speech (HP:0002371) | 1.91628838 |
| 109 | Neuronal loss in central nervous system (HP:0002529) | 1.91094359 |
| 110 | Dilatation of the ascending aorta (HP:0005111) | 1.90829447 |
| 111 | Esophageal varix (HP:0002040) | 1.90757340 |
| 112 | Abnormal platelet volume (HP:0011876) | 1.90121531 |
| 113 | Progressive neurologic deterioration (HP:0002344) | 1.89924895 |
| 114 | Pustule (HP:0200039) | 1.89901332 |
| 115 | Axonal loss (HP:0003447) | 1.89800405 |
| 116 | Increased serum ferritin (HP:0003281) | 1.89488156 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 1.89371459 |
| 118 | Hypolipoproteinemia (HP:0010981) | 1.89025935 |
| 119 | Ectopia lentis (HP:0001083) | 1.88773070 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 1.88484532 |
| 121 | Keratoconjunctivitis sicca (HP:0001097) | 1.88093219 |
| 122 | Vertebral compression fractures (HP:0002953) | 1.86590574 |
| 123 | Amyloidosis (HP:0011034) | 1.86157307 |
| 124 | Osteomyelitis (HP:0002754) | 1.85980056 |
| 125 | Thrombophlebitis (HP:0004418) | 1.85725669 |
| 126 | Polygenic inheritance (HP:0010982) | 1.84790017 |
| 127 | Cervical subluxation (HP:0003308) | 1.84762499 |
| 128 | Pulmonary embolism (HP:0002204) | 1.84186846 |
| 129 | Premature rupture of membranes (HP:0001788) | 1.84160019 |
| 130 | Bone pain (HP:0002653) | 1.83632737 |
| 131 | Joint stiffness (HP:0001387) | 1.83569579 |
| 132 | Menorrhagia (HP:0000132) | 1.83117427 |
| 133 | Ketoacidosis (HP:0001993) | 1.81463142 |
| 134 | Distal lower limb muscle weakness (HP:0009053) | 1.81324234 |
| 135 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.80910373 |
| 136 | Premature loss of primary teeth (HP:0006323) | 1.79946931 |
| 137 | Hypercholesterolemia (HP:0003124) | 1.79846146 |
| 138 | Restrictive lung disease (HP:0002091) | 1.78753582 |
| 139 | Abnormality of purine metabolism (HP:0004352) | 1.78577176 |
| 140 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.78500851 |
| 141 | Pathologic fracture (HP:0002756) | 1.78201495 |
| 142 | Increased mean platelet volume (HP:0011877) | 1.78034761 |
| 143 | Lymphangioma (HP:0100764) | 1.77995657 |
| 144 | Mitral valve prolapse (HP:0001634) | 1.77665400 |
| 145 | Mutism (HP:0002300) | 1.77102931 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.76978492 |
| 147 | Abnormality of the peritoneum (HP:0002585) | 1.76783831 |
| 148 | Diminished motivation (HP:0000745) | 1.75790247 |
| 149 | Apathy (HP:0000741) | 1.75215195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.77036101 |
| 2 | TRIB3 | 4.03183197 |
| 3 | MAP4K1 | 3.54247348 |
| 4 | PKN2 | 3.43610354 |
| 5 | PRPF4B | 3.19135404 |
| 6 | MAP3K10 | 2.87605471 |
| 7 | EEF2K | 2.71389985 |
| 8 | TGFBR2 | 2.42066605 |
| 9 | FLT3 | 2.33575874 |
| 10 | KIT | 2.31750045 |
| 11 | TYK2 | 2.31524526 |
| 12 | TBK1 | 2.25128780 |
| 13 | BCKDK | 2.11399781 |
| 14 | FGFR4 | 2.07090767 |
| 15 | CSF1R | 2.02411135 |
| 16 | KDR | 1.87019846 |
| 17 | BLK | 1.84020292 |
| 18 | TAOK2 | 1.80563152 |
| 19 | LRRK2 | 1.76984284 |
| 20 | SIK1 | 1.74264119 |
| 21 | TTN | 1.67598383 |
| 22 | MAP2K3 | 1.67013227 |
| 23 | ZAP70 | 1.53662480 |
| 24 | PTK6 | 1.52388339 |
| 25 | TAOK3 | 1.48700154 |
| 26 | JAK1 | 1.48337448 |
| 27 | BTK | 1.45932736 |
| 28 | JAK3 | 1.44935052 |
| 29 | GRK6 | 1.44473546 |
| 30 | CDC42BPA | 1.42623624 |
| 31 | DDR2 | 1.42485369 |
| 32 | STK10 | 1.39990147 |
| 33 | SMG1 | 1.39873572 |
| 34 | EPHB1 | 1.39326630 |
| 35 | RIPK1 | 1.36766264 |
| 36 | SCYL2 | 1.34208659 |
| 37 | FGR | 1.31902956 |
| 38 | NME2 | 1.29546263 |
| 39 | GRK7 | 1.26456212 |
| 40 | TIE1 | 1.22996881 |
| 41 | MOS | 1.20186729 |
| 42 | SYK | 1.19105218 |
| 43 | PRKD2 | 1.14832797 |
| 44 | TESK1 | 1.12933484 |
| 45 | NEK9 | 1.10073877 |
| 46 | CSK | 1.07924453 |
| 47 | IKBKE | 1.06041615 |
| 48 | RPS6KA4 | 1.03878319 |
| 49 | ICK | 1.03746199 |
| 50 | HCK | 1.00280852 |
| 51 | TGFBR1 | 0.97616668 |
| 52 | MAP3K11 | 0.97086057 |
| 53 | KSR2 | 0.93645460 |
| 54 | ARAF | 0.90760237 |
| 55 | MAPK11 | 0.88251371 |
| 56 | TNK2 | 0.86814257 |
| 57 | ITK | 0.86673574 |
| 58 | PAK4 | 0.86055505 |
| 59 | PIM2 | 0.85580404 |
| 60 | JAK2 | 0.85456024 |
| 61 | MAPKAPK3 | 0.85003663 |
| 62 | PDGFRA | 0.83144057 |
| 63 | MARK2 | 0.83036800 |
| 64 | FES | 0.82908543 |
| 65 | MAP3K13 | 0.81985568 |
| 66 | TEC | 0.81213663 |
| 67 | MAP3K7 | 0.78752338 |
| 68 | IRAK4 | 0.77612065 |
| 69 | RPS6KA2 | 0.77170273 |
| 70 | MAP3K6 | 0.75900578 |
| 71 | FGFR3 | 0.75564682 |
| 72 | SIK2 | 0.74650658 |
| 73 | MAPK7 | 0.73472212 |
| 74 | LCK | 0.71314638 |
| 75 | LYN | 0.70896079 |
| 76 | MATK | 0.68634278 |
| 77 | MAPK12 | 0.68338496 |
| 78 | SIK3 | 0.67147865 |
| 79 | CAMK1D | 0.66815796 |
| 80 | IKBKB | 0.66524506 |
| 81 | MAP3K14 | 0.64346586 |
| 82 | MAP3K3 | 0.61871171 |
| 83 | CLK1 | 0.61228067 |
| 84 | TXK | 0.59611781 |
| 85 | CDK12 | 0.57614848 |
| 86 | MARK3 | 0.57135987 |
| 87 | PIM1 | 0.56696432 |
| 88 | PIK3CG | 0.56586030 |
| 89 | IRAK2 | 0.56568886 |
| 90 | PAK2 | 0.55409826 |
| 91 | HIPK2 | 0.54517170 |
| 92 | TAOK1 | 0.54058512 |
| 93 | MAP3K8 | 0.52436143 |
| 94 | IRAK3 | 0.52390590 |
| 95 | RET | 0.52135434 |
| 96 | PRKCH | 0.50999451 |
| 97 | MAPK4 | 0.50875085 |
| 98 | ILK | 0.49423511 |
| 99 | TRPM7 | 0.48737113 |
| 100 | TESK2 | 0.46992821 |
| 101 | MAP3K5 | 0.46877678 |
| 102 | CDK4 | 0.46582441 |
| 103 | BMX | 0.45667938 |
| 104 | MAPKAPK2 | 0.44646522 |
| 105 | CDK6 | 0.42515050 |
| 106 | MYLK | 0.42051741 |
| 107 | RIPK4 | 0.42005237 |
| 108 | PDK1 | 0.41995029 |
| 109 | MAP3K1 | 0.41028261 |
| 110 | DYRK1B | 0.40730837 |
| 111 | IRAK1 | 0.40635694 |
| 112 | BMPR2 | 0.39956048 |
| 113 | RPS6KA6 | 0.38546246 |
| 114 | FYN | 0.38176002 |
| 115 | RPS6KB2 | 0.37329980 |
| 116 | EPHA3 | 0.36770692 |
| 117 | PRKG2 | 0.36554114 |
| 118 | CAMKK1 | 0.36124229 |
| 119 | EGFR | 0.35154224 |
| 120 | PTK2 | 0.34848834 |
| 121 | PRKD1 | 0.33634191 |
| 122 | PDPK1 | 0.33500594 |
| 123 | PDGFRB | 0.31892929 |
| 124 | MTOR | 0.30814571 |
| 125 | ABL2 | 0.30808643 |
| 126 | RPS6KL1 | 0.30479640 |
| 127 | RPS6KC1 | 0.30479640 |
| 128 | CHUK | 0.30236544 |
| 129 | ABL1 | 0.30208904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.91460604 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.65212596 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.55762562 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55301979 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.37598688 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36737280 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24780653 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.10763621 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.08839089 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93870593 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93371374 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.91455388 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.90039017 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.85592865 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85499106 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.78446929 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.73160140 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72833207 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70670492 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65381429 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.63996657 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63239747 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62467668 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56099811 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55247889 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.54572462 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48499379 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39795065 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36052202 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.35156297 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30351881 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29888846 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29643615 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27559934 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25417929 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.24092798 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20983639 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.19565490 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18978867 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17050734 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15392871 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.15234624 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12465480 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11954256 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09720217 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06686412 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06358191 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.06122221 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.05591995 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03772353 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02699976 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 1.02142474 |
| 53 | Malaria_Homo sapiens_hsa05144 | 1.01309842 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 1.01286112 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 0.99777367 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96587624 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95049277 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93233474 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93006876 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92484022 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.90883246 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.90798886 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90346907 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89270340 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88428957 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88192661 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.87765544 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87274882 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84002208 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82926927 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82567084 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82117400 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80964677 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80769744 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79406012 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79398837 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78789251 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78455849 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78412820 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78077579 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.77312961 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76901171 |
| 83 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76510142 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76480521 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76297812 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75535646 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74937120 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74557516 |
| 89 | Legionellosis_Homo sapiens_hsa05134 | 0.74292784 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.73799867 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73187859 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72121039 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71301562 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.70200042 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69212017 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68542801 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67008889 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66933409 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.66681644 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65337502 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.65227479 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65033047 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64909117 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64127154 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63924509 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62465375 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61593364 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.61528016 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60808194 |
| 110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60778091 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60038073 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59394922 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58898970 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58563953 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58222389 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57268372 |
| 117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56858563 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56051847 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53984853 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.53753598 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53742091 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53455417 |
| 123 | Hepatitis B_Homo sapiens_hsa05161 | 0.53427391 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52526052 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52457646 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51988565 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51350395 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50935193 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50849418 |
| 130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50538001 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49759954 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49480008 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47965421 |
| 134 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47889056 |
| 135 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47845235 |
| 136 | Focal adhesion_Homo sapiens_hsa04510 | 0.46883538 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.44635093 |
| 138 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44469209 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43172250 |
| 140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43141016 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41293295 |
| 142 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41102160 |
| 143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40295949 |
| 144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36873818 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35919071 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32648936 |
| 147 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32635380 |

